Highest rating for VERTEX PHARMACEUTICALS INC using P/B Growth Investor model, interest indicated.

From Nasdaq: 2025-01-11 13:00:00

Validea’s guru fundamental report for VERTEX PHARMACEUTICALS INC (VRTX) rates highest using the P/B Growth Investor model by Partha Mohanram. VRTX is a large-cap value stock in the Biotechnology & Drugs industry. The stock’s rating based on this strategy is 77%, indicating interest. Criteria like book/market ratio and return on assets pass, while advertising to assets fails. Partha Mohanram, known for his growth model, has produced significant market outperformance with his research on separating winners from losers among low book-to-market stocks. Validea is an investment research service that follows the strategies of investment legends like Warren Buffett and Peter Lynch.



Read more at Nasdaq: VRTX Quantitative Stock Analysis | Nasdaq